Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis

Objective. To assess the efficacy and safety profiles of two different rituximab retreatment regimens in patients with RA.

Bibliographic Details
Main Authors: Emery, Paul, Mease, Philip J., Rubbert-Roth, Andrea, Curtis, Jeffrey R., Müller-Ladner, Ulf, Gaylis, Norman B., Williams, Sarah, Reynard, Mark, Tyrrell, Helen
Format: Online
Language:English
Published: Oxford University Press 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222846/